Drugs for Gastrointestinal Diseases — Flashcards

Proton pump inhibitors (PPIs) _____ inhibit the H+/K+-ATPase pump, which is the final common pathway for H+ secretion

_____ is a surfactant that decreases foaming and is included in many antacid preparations to reduce gastroesophageal reflux.

Ursodeoxycholic acid acts via increasing _____ secretion and decreasing cholesterol secretion/reabsorption

_____ is a GLP-2 analogue

_____ acts by inhibiting the cAMP-stimulated CFTR chloride channel and calcium-activated chloride channels on the luminal side of intestine.

Hint: Anti-diarrheal

Misoprostol promotes increased production and secretion of a gastric _____ barrier and decreased acid production

First Aid Pharmacology: GI_____ is a combination drug that may be used to treat ulcerative colitis and Crohn disease (colitis component)

_____ is the oral PPI preparation that causes fastest acid suppression

Gastric bezoars are commonly associated with antacids such as _____.

_____ is approved for treatment of short-bowel syndrome